In order to understand the potential mechanisms that underlie the ameliorative effects of rTMS on systemic insulin sensitivity and weight loss in T2D rats, we extracted liver and hypothalamus samples from both experimental groups at the end of the rTMS‐treated period and RNA‐seq analysis was performed. The gene discussed is INS; the disease is type 2 diabetes mellitus.